XBI

Fund Description
The SPDR S&P Biotech ETF before expenses seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index (ticker: SPSIBITR).
Fund Profile
Fund Name SPDR S&P Biotech ETF
Fund Exchange Ticker XBI
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A8707
Net Expense Ratio 0.35 %
Fund Inception Date 31 January 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Biotech Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 19 March 2019
Asset Under Management 4407.53 Million (USD)
1 Month Total Return 5.37 %
Year To Date Return 27.16 %
1 Year Total Return -2.34 %
3 Year Annualized Total Return 23.92 %
NAV 91.2533
Share Outstanding 48,300,000
Top 10 Holdings (19 March 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
LIGAND PHARMACEUTICALS LGND EQUI 0.0173701700
IMMUNOMEDICS INC IMMU EQUI 0.0170591800
NEUROCRINE BIOSCIENCES INC NBIX EQUI 0.0169126700
IONIS PHARMACEUTICALS INC IONS EQUI 0.0167619800
BLUEBIRD BIO INC BLUE EQUI 0.0166805800
ARRAY BIOPHARMA INC ARRY EQUI 0.0164879700
INTERCEPT PHARMACEUTICALS IN ICPT EQUI 0.0164566300
UNITED THERAPEUTICS CORP UTHR EQUI 0.0159136600
EXACT SCIENCES CORP EXAS EQUI 0.0158410400
ALNYLAM PHARMACEUTICALS INC ALNY EQUI 0.0157916800